Summary:
Double-blind, placebo-controlled, parallel group study to assess the efficacy, safety and tolerability of an investigational medication (twice a montth) for patients with primary Hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events. 1-2 years with 20 office visits.
Qualified Participants Must:
• Be 18 years of age, or older
•
Have High Cholesterol
•
Be taking a daily statin.
Qualified Participants May Receive:
Study medication, study related exams and labs, and compensation for time and travel.